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On the Path to an AIDS-Free Generation:  
A Bold New Approach Saves Mothers and Babies 
 
he inspiring vision of an AIDS-free generation—as powerfully articulated by 
President Obama in his 2013 State of the Union address—took a leap forward 
in the developing nation of Malawi recently, where CDC supported the 
implementation of an innovative new approach to eliminate mother-to-child HIV 
transmission. CDC is a key partner in the U.S. President’s Plan for AIDS Relief 
(PEPFAR), which has saved millions of lives in the global HIV/AIDS epidemic.  
 
The new approach, called Option B+, offers all HIV-positive pregnant or 
breastfeeding women lifesaving antiretroviral treatment (ART) for their entire 
lives. Option B+ simplifies the ART regimen to one pill once a day making it much 
easier for the patient to take and far easier to implement. 
 
Not only does this approach help to ensure mother-to-child transmission is 
reduced to less than 5 percent for all future pregnancies but it also maintains the mother’s health, reduces HIV transmission to 
uninfected sexual partners, and prevents all of her children from becoming orphaned. Simplifying treatment has had significant 
impact.  One year after implementation of this approach, the number of HIV-positive pregnant and breastfeeding women on ART 
increased by more than 700 percent.1 
 
Breaking through the access barrier 
Mother-to-child HIV transmission can occur during pregnancy, labor, delivery, or breastfeeding. Although maternal HIV 
transmission has been virtually eliminated in the developed world, in 2011 only 57 percent of pregnant women with HIV in low 
and middle-income countries received an antiretroviral drug regimen recommended by the World Health Organization. That 
same year, 300,000 infants acquired HIV infection from their mothers in sub-Saharan Africa, 5.2 percent of whom were in 
Malawi. 
 
Malawi is a low-income country of 15 million people and ranks among the 22 highest burden countries for new infant HIV 
infections globally. A barrier to increasing ART services in Malawi and in other similar settings is the limited laboratory capacity 
for CD4 cell count analysis needed for other PMTCT approaches (Option A and Option B) to determine when to start lifelong ART 
based on the stage of a woman’s HIV infection. Option B+ provides lifelong ART to all HIV-positive pregnant and breastfeeding 
women regardless of CD4 count or clinical stage. In addition to making treatment easier and more available, Option B+ addresses 
the needs of HIV-positive women throughout their reproductive years, rather than as a time-limited intervention provided only 
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Simplifying the treatment regimen 
In addition to starting women earlier on lifelong ART, Option B+ enabled 
women in Malawi to receive ART and prenatal care in the same clinic, and 
required only a positive rapid HIV test result to initiate treatment. The 
approach simplified ART to a one pill, once-a-day regimen, and 
standardized ART training and messaging for healthcare workers. This 
allows for decentralization of service delivery, a critical step toward 
increasing access. Healthcare workers find the new approach more 
intuitive and are gratified to be empowered to save the lives of Malawi 
women and their babies. 
 
The results of this approach have been impressive: the number of HIV-
positive pregnant and breastfeeding women started on ART increased by 
748 percent to 10,663 in the third quarter of 2012 (one year after 
implementation of Option B+) from 1,257 in the second quarter of 2011 
(before Option B+). The percent of pregnant and breastfeeding women 
who remained on Option B+ twelve months after initiation (77 percent) 
was similar to the 12-month ART retention rate among adults who 
initiated ART prior to Option B+ implementation (80 percent). 
 
The voices of Malawian women attest to the impact this approach has 
had on their lives: “It is good to have an HIV-free child when you are 
reactive. My first child died prematurely from HIV,” said one. “I am happy 
to start ART early, as I will not become sick from HIV and [I can] go 
unnoticed,” noted another. “I would actually recommend this policy to all 
my friends who happen to be in my position.” 
 
CDC expertise a critical component  
CDC played a major role in implementing Option B+ in Malawi under the 
direction of the Malawi Ministry of Health and supported by PEPFAR. 
Support to the ministry included: funding for preparatory activities and 
trainings, technical assistance through embedding subject matter experts 
in the ministry, revision of the National Clinical Guidelines for HIV 
treatment and training curricula for healthcare workers, implementing a 
clinical mentoring program to supplement the existing national quarterly 
supportive supervision system, increasing national laboratory capacity for 
viral load and early infant diagnosis testing, and strengthening health 
information systems and data quality assurance. CDC also plans to 
conduct an evaluation on the impact of Option B+ over the next four years 
in collaboration with the Malawi Ministry of Health.
 
Moving toward an AIDS-free generation 
Option B+ represents an important milestone 
toward achieving an AIDS-free generation. While 
Malawi was the first country to adopt it, other 
countries  implementing or planning to 
implement this approach in the near future 
include Cameroon, Democratic Republic of the 
Congo, the Dominican Republic, Ethiopia, Haiti, 
Kenya, Mozambique, Namibia, Rwanda, 
Tanzania, Uganda, and Zambia.  
 
Success in implementing this approach across 
countries with high HIV burdens can help achieve 
the commitment made by President Obama on 
World AIDS Day 2011 for the United States to 
support 6 million people on ART and provide 
antiretroviral drugs for 1.5 million HIV infected 
pregnant women by the end of 2013. 
 
Option B+ is also important for accelerating 
progress toward eliminating new HIV infections 
in children by 2015 and keeping HIV-positive 
mothers alive, the goals of a global action plan 





As a lead implementing agency for PEPFAR, CDC provides technical 
expertise to more than 75 countries worldwide. For more details 
on CDC’s innovations and contributions to creating an AIDS-free 
generation, please visit www.cdc.gov/globalaids. 
